Influence of muscle glycogen content on metabolic regulation.
Euglycemia was maintained in 13 subjects with low muscle glycogen [low glycogen, euglycemic (LGE), n = 8; low glycogen, euglycemic, hyperinsulinemic (LGEI), n = 5] and 6 subjects with normal muscle glycogen (NGE), whereas hyperglycemia was maintained in 8 low muscle glycogen subjects (LGH). All subjects cycled for 145 min at 70% of maximal oxygen uptake during the infusions. Insulin was infused in LGEI at 0.2 mU.kg-1.min-1. During exercise, respiratory exchange ratio (RER) was lower and norepinephrine higher in LGE than in NGE. In LGEI and LGH, RER at the start of exercise was the same as in LGE but did not decrease as in LGE. Free fatty acids (FFA) were higher and plasma insulin concentrations lower in LGE than NGE, LGEI, or LGH over the first 45 min of exercise. Rate of glucose infusion (Ri) and rate of glucose oxidation (Rox) were higher in LGH and LGEI than in NGE or LGE, and Ri matched Rox in all groups except LGH, in which Ri was greater than Rox. Muscle glycogen disappearance was greater in NGE than LGE, LGEI, or LGH, but the latter three groups did not differ. In conclusion, this study showed that low muscle glycogen content results in a decrease in RER, an increase in FFA, fat oxidation, and norepinephrine both at rest and during exercise, and does not affect Rox when euglycemia is maintained by infusion of glucose alone. Rox was increased only during insulin and hyperglycemia.
Weltan
S M
SM
Department of Physiology, University of Cape Town Medical School, Observatory, South Africa.
Bosch
A N
AN
Dennis
S C
SC
Noakes
T D
TD
D000328:Adult; D001642:Bicycling; D001786:Blood Glucose / Q000378:metabolism; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D002149:Energy Intake; D004734:Energy Metabolism; D005080:Exercise Test; D005934:Glucagon / Q000097:blood / Q000378:metabolism; D015309:Glucose Clamp Technique; D006003:Glycogen / Q000378:metabolism*; D006801:Humans; D006943:Hyperglycemia; D007262:Infusions, Intravenous; D007328:Insulin / Q000008:administration & dosage / Q000494:pharmacology; D007773:Lactates / Q000097:blood; D008297:Male; D018763:Muscle Fatigue; D018482:Muscle, Skeletal / Q000187:drug effects / Q000502:physiology*; D010101:Oxygen Consumption; D010807:Physical Endurance / Q000502:physiology*
D001786:Blood Glucose; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D007328:Insulin; D007773:Lactates; D006003:Glycogen; D005934:Glucagon